Litcius/Paper detail

Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399)

Yee Pei Song, Hitesh Mistry, Joely J. Irlam, Helen Valentine, Lingjian Yang, Brian R. Lane, Catharine West, Ananya Choudhury, Peter Hoskin

2021International Journal of Radiation Oncology*Biology*Physics76 citationsDOIOpen Access PDF

Topics & Concepts

CarbogenMedicineNicotinamideRadiation therapyHypoxia (environmental)OncologyRandomized controlled trialInternal medicineBiomarkerChemistryOxygenBiochemistryEnzymeOrganic chemistryBladder and Urothelial Cancer TreatmentsUrological Disorders and TreatmentsUrinary Bladder and Prostate Research
Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399) | Litcius